Blake Chancellor assists the Biotechnology Practice in patent drafting, patent prosecution, prior art searching, freedom-to-operate analyses, due diligence support, and IP portfolio management in the areas of molecular and cellular biology, synthetic biology, genetic engineering, proteomics, and genomics. He has extensive knowledge in the areas of molecular and cellular biology, molecule neuroscience, computational biology, and genomics.
Prior to joining Wolf Greenfield, Blake earned a doctorate degree in Genetics and Genomics at Harvard University, where his thesis research focused on genomic analyses of human neurodegenerative tauopathies. During this time, he applied single-cell transcriptomic analyses to reveal the contribution of individual brain cells in human white matter brain tissue to Chronic Traumatic Encephalopathy and Alzheimer’s disease.
- Harvard Brain Science Initiative Young Scientist Development Award
- Harvard Graduate School of Arts and Sciences Graduate Prize Fellowship
- Chancellor KB, Chancellor SE, Duke-Cohan JE, Huber BR, Stein TD, Alvarez VE, Okaty BW, Dymecki SM, McKee AC. Altered oligodendroglia and astroglia in chronic traumatic encephalopathy. Acta Neuropathol. 2021;142(2):295–321.